News & Blogs

Read our latest news and explore our blog posts

MOVE TO:

1 June, 2026

Prediction or speculation: heart failure models for diabetes – An Editorial comment from iCARE4CVD

Can we predict heart failure in people with diabetes, or are we merely speculating? That is the question explored in a recent iCARE4CVD editorial, which discusses a large meta-analysis evaluating more than 50 prediction models designed to identify individuals with type 2 diabetes who are at risk of developing heart failure or being hospitalised because of it.
Read more

2 April, 2026

Connecting Health Data for Better Heart Failure Monitoring (SWAT4HCLS conference)

At the SWAT4HCLS conference, iCARE4CVD presented new research introducing the Digital Biomarker..
Read more

15 January, 2026

CMEO: making heart disease and clinical studies easier to find, compare, and reuse

Across Europe, vast amounts of heart disease data already exist—but they are..
Read more

15 January, 2026

Beyond medical results: Using Patient-Reported Outcomes and Experiences in heart care – a scoping review

In a recent scoping review, we examined 390 studies to understand how..
Read more

2 January, 2026

iCARE4CVD salutes the new EU cardiovascular Health Plan!

With the new EU Cardiovascular Health Plan launched – iCARE4CVD welcomes the..
Read more

1 October, 2025

iCARE4CVD’s five recommendations for the EU Cardiovascular Health Plan

The iCARE4CVD consortium is urging the European Union (EU) to place personalised..
Read more

7 August, 2025

The CDE-Mapper: iCARE4CVD’s new AI-based tool to standardise health data

iCARE4CVD researchers unveil the CDE-Mapper: an innovative AI tool using Retrieval-Augmented Generation..
Read more

Subscribe to our newsletter

Subscribe to our newsletter to stay up to date with all the most recent information about iCARE4CVD.

Funding acknowledgment

This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) and Breakthrough T1D under grant agreement No 101112022. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, Vaccines Europe, EuropaBio and MedTech Europe.

Disclaimer

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the aforementioned parties. Neither of the aforementioned parties can be held responsible for them.

Quick Links